Nuformix plc (LON:NFX – Get Free Report)’s share price reached a new 52-week low during trading on Tuesday . The stock traded as low as GBX 0.14 ($0.00) and last traded at GBX 0.15 ($0.00), with a volume of 2880428 shares. The stock had previously closed at GBX 0.15 ($0.00).
Nuformix Price Performance
The company has a quick ratio of 3.35, a current ratio of 1.12 and a debt-to-equity ratio of 1.17. The company has a fifty day simple moving average of GBX 0.17 and a 200 day simple moving average of GBX 0.18. The firm has a market capitalization of £1.27 million, a P/E ratio of -1.63 and a beta of 1.22.
Nuformix Company Profile
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
See Also
- Five stocks we like better than Nuformix
- Options Trading – Understanding Strike Price
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- How to Calculate Inflation Rate
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
